A Susceptible Cell‐Selective Delivery (SCSD) of mRNA‐Encoded Cas13d Against Influenza Infection
Advanced Science · 2025
DOI: 10.1002/advs.202414651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Zhuanli Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, RNA, Messenger, Influenza A virus, Orthomyxoviridae Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Joint Program on Health Science & Technology Innovation of Hainan Province.
Abstract (Originalsprache)
To bolster the capacity for managing potential infectious diseases in the future, it is critical to develop specific antiviral drugs that can be rapidly designed and delivered precisely. Herein, a CRISPR/Cas13d system for broad‐spectrum targeting of influenza A virus (IAV) from human, avian, and swine sources is designed, incorporating Cas13d mRNA and a tandem CRISPR RNA (crRNA) specific for the highly conserved regions of viral polymerase acidic (PA), nucleoprotein (NP), and matrix (M) gene segments, respectively. Given that the virus targets cells with specific receptors but is not limited to a single organ, a Susceptible Cell Selective Delivery (SCSD) system is developed by modifying a lipid nanoparticle with a peptide mimicking the function of the hemagglutinin of influenza virus to target sialic acid receptors. The SCSD system can precisely deliver an all‐RNA‐based CRISPR/Cas13d system into potentially infected cells. This drug is shown to reduce the viral load in the lungs by 2.37 log 10 TCID 50 mL −1 and protect 100% of mice from lethal influenza infection. The SCSD‐based CRISPR/Cas13d system shows promise for the flexible and efficient therapy of infections caused by rapidly evolving and novel viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China.
- Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases of the Ministry of Agriculture and Ru…
- State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing, 100193, China.
- Sanya Institute of China Agricultural University, Hainan, 572025, China.
- Veterinary Teaching Hospital, China Agricultural University, Beijing, 100193, China.
- Beijing Key Laboratory of Detection Technology for Animal-Derived Food Safety, Beijing, 100193, China.
ORCID-Profile: Yipeng Sun
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Joint Program on Health Science & Technology Innovation of Hainan Province
Zitieren
APA
Wu, Z., Zhao, C., Ai, H., Wang, Z., Chen, M., Lyu, Y., Tong, Q., Liu, L., Sun, H., Pu, J., Zhang, R., Hu, X., Liu, J., Ma, X., & Sun, Y. (2025). A Susceptible Cell‐Selective Delivery (SCSD) of mRNA‐Encoded Cas13d Against Influenza Infection. Advanced Science. https://doi.org/10.1002/advs.202414651
Vancouver
Wu Z, Zhao C, Ai H, Wang Z, Chen M, Lyu Y, et al. A Susceptible Cell‐Selective Delivery (SCSD) of mRNA‐Encoded Cas13d Against Influenza Infection. Advanced Science. 2025. doi:10.1002/advs.202414651
BibTeX
@article{Wu2025,
author = {Wu, Zhuanli and Zhao, Chengcheng and Ai, Hui and Wang, Zhen and Chen, Mingyue and Lyu, Yanli and Tong, Qi and Liu, Litao and Sun, Honglei and Pu, Juan and Zhang, Ran and Hu, Xiaoxiang and Liu, Jinhua and Ma, Xiaowei and Sun, Yipeng},
title = {A Susceptible Cell‐Selective Delivery (SCSD) of mRNA‐Encoded Cas13d Against Influenza Infection},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202414651}
}
EUVIMED